References
Pleij H (2001) Dreaming of Cockaigne. Medieval fantasies of the perfect life. Columbia University Press, New York
Barker DJ (2007) Obesity and early life. Obes Rev 8(Suppl 1):45–49
Sobal J, Stunkard AJ (1989) Socioeconomic status and obesity: a review of the literature. Psychol Bull 105:260–275
Stunkard AJ, Wadden TA (1992) Psychological aspects of severe obesity. Am J Clin Nutr 55:524S–532S
Connolly HM, Crary JL, McGoon MD et al (1997) Valvular heart disease associated with fenfluramine–phentermine. N Engl J Med 337:581–588
Polak J, Oakley CM, Yacoub M, Mikhail G, Taylor-Robinson SD (1998) Primary pulmonary hypertension: pathologist as patient. J R Coll Physicians Lond 32:225–230
MacDonald KG Jr (2003) Overview of the epidemiology of obesity and the early history of procedures to remedy morbid obesity. Arch Surg 138:357–360
Mason EE, Ito C (1967) Gastric bypass in obesity. Surg Clin North Am 47:1345–1351
Karlsson J, Taft C, Ryden A, Sjostrom L, Sullivan M (2007) Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS Intervention Study. Int J Obes (Lond) 31:1248–1261
Gleysteen JJ, Barboriak JJ, Sasse EA (1990) Sustained coronary-risk-factor reduction after gastric bypass for morbid obesity. Am J Clin Nutr 51:774–778
Sjostrom L, Lindroos AK, Peltonen M et al (2004) Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351:2683–2693
Sjostrom L, Narbro K, Sjostrom CD et al (2007) Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357:741–752
Mattar SG, Velcu LM, Rabinovitz M et al (2005) Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome. Ann Surg 242:610–617, discussion 618–620
Hooper MM, Stellato TA, Hallowell PT, Seitz BA, Moskowitz RW (2007) Musculoskeletal findings in obese subjects before and after weight loss following bariatric surgery. Int J Obes (Lond) 31:114–120
Sugerman HJ, Felton WL 3rd, Salvant JB Jr, Sismanis A, Kellum JM (1995) Effects of surgically induced weight loss on idiopathic intracranial hypertension in morbid obesity. Neurology 45:1655–1659
Haines KL, Nelson LG, Gonzalez R et al (2007) Objective evidence that bariatric surgery improves obesity-related obstructive sleep apnea. Surgery 141:354–358
Eid GM, Cottam DR, Velcu LM et al (2005) Effective treatment of polycystic ovarian syndrome with Roux-en-Y gastric bypass. Surg Obes Relat Dis 1:77–80
Salem L, Devlin A, Sullivan SD, Flum DR (2008) Cost-effectiveness analysis of laparoscopic gastric bypass, adjustable gastric banding, and nonoperative weight loss interventions. Surg Obes Relat Dis 4:26–32
Keating CL, Dixon JB, Moodie ML et al (2009) Cost-effectiveness of surgically induced weight loss for the management of type 2 diabetes: modeled lifetime analysis. Diab Care 32:567–574
Keating CL, Dixon JB, Moodie ML, Peeters A, Playfair J, O’Brien PE (2009) Cost-efficacy of surgically induced weight loss for the management of type 2 diabetes: a randomized controlled trial. Diab Care 32:580–584
Cowan GS Jr (1992) The future of bariatric surgery. Obes Surg 2:169–176
Libeton M, Dixon JB, Laurie C, O’Brien PE (2004) Patient motivation for bariatric surgery: characteristics and impact on outcomes. Obes Surg 14:392–398
Munoz DJ, Lal M, Chen EY et al (2007) Why patients seek bariatric surgery: a qualitative and quantitative analysis of patient motivation. Obes Surg 17:1487–1491
American Diabetes Association (2010) Standards of medical care in diabetes—2010. Diab Care 33:S11
National Institute for Health and Clinical Excellence (2006) Clinical guideline 43. Obesity. Guidance on the prevention, identification, assessment and management of overweight and obesity in adults and children. National Institute for Health and Clinical Excellence, London
Rubino F, Kaplan LM, Schauer PR, Cummings DE (2010) The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann Surg 251:399–405
West KM (1978) Epidemiology of diabetes and its vascular lesions. Elsevier, New York
Trowell H (1974) Diabetes mellitus death rates in England and Wales 1920–70 and food supplies. Lancet 2:998–1002
Westlund K (1966) Incidence of diabetes mellitus in Oslo, Norway, 1925 to 1954. Br J Prev Soc Med 20:105–116
Buchwald H, Estok R, Fahrbach K et al (2009) Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 122:248–256, e245
Chipkin SR, Goldberg RJ (2009) Obesity surgery and diabetes: does a chance to cut mean a chance to cure? Am J Med 122:205–206
Dixon JB, O’Brien PE, Playfair J et al (2008) Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 299:316–323
Dixon JB, O’Brien PE (2002) Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding. Diab Care 25:358–363
Thaler JP, Cummings DE (2009) Hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology 150:2518–2525
Chapman AE, Kiroff G, Game P et al (2004) Laparoscopic adjustable gastric banding in the treatment of obesity: a systematic literature review. Surgery 135:326–351
Parikh M, Ayoung-Chee P, Romanos E et al (2007) Comparison of rates of resolution of diabetes mellitus after gastric banding, gastric bypass, and biliopancreatic diversion. J Am Coll Surg 205:631–635
Zalesin K (2009) P-18: differential loss of fat and lean mass in the morbidly obese after bariatric surgery. Surg Obes Relat Dis 5(Suppl):S29–S30
Geloneze B, Geloneze SR, Fiori C et al (2009) Surgery for nonobese type 2 diabetic patients: an interventional study with duodenal–jejunal exclusion. Obes Surg 19:1077–1083
Schauer PR, Burguera B, Ikramuddin S et al (2003) Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 238:467–484, discussion 484–465
Chikunguwo SM, Wolfe LG, Dodson P et al (2010) Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass. Surg Obes Relat Dis 6:254–259
UK Prospective Diabetes Study Group (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 317:703–713
Collins R, Armitage J, Parish S, Sleigh P, Peto R (2003) MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 361:2005–2016
Buchwald H, Estok R, Fahrbach K, Banel D, Sledge I (2007) Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery 142:621–632, discussion 632–625
Morino M, Toppino M, Forestieri P, Angrisani L, Allaix ME, Scopinaro N (2007) Mortality after bariatric surgery: analysis of 13,871 morbidly obese patients from a national registry. Ann Surg 246:1002–1007, discussion 1007–1009
Flum DR, Belle SH, King WC et al (2009) Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med 361:445–454
Omalu BI, Ives DG, Buhari AM et al (2007) Death rates and causes of death after bariatric surgery for Pennsylvania residents, 1995 to 2004. Arch Surg 142:923–928, discussion 929
Varela JE, Wilson SE, Nguyen NT (2006) Outcomes of bariatric surgery in the elderly. Am Surg 72:865–869
Kellogg TA, Swan T, Leslie DA, Buchwald H, Ikramuddin S (2009) Patterns of readmission and reoperation within 90 days after Roux-en-Y gastric bypass. Surg Obes Relat Dis 5:416–423
Hallowell PT, Stellato TA, Yao DA, Robinson A, Schuster MM, Graf KN (2009) Should bariatric revisional surgery be avoided secondary to increased morbidity and mortality? Am J Surg 197:391–396
Pories WJ, Swanson MS, MacDonald KG et al (1995) Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 222:339–350, discussion 350–352
Shah M, Simha V, Garg A (2006) Review: long-term impact of bariatric surgery on body weight, comorbidities, and nutritional status. J Clin Endocrinol Metab 91:4223–4231
Clements RH, Katasani VG, Palepu R et al (2006) Incidence of vitamin deficiency after laparoscopic Roux-en-Y gastric bypass in a university hospital setting. Am Surg 72:1196–1202, discussion 1203–1204
Mechanick JI, Kushner RF, Sugerman HJ et al (2008) American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery Medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Endocr Pract 14(Suppl 1):1–83
Fleischer J, Stein EM, Bessler M et al (2008) The decline in hip bone density after gastric bypass surgery is associated with extent of weight loss. J Clin Endocrinol Metab 93:3735–3740
Aasheim ET (2008) Wernicke encephalopathy after bariatric surgery: a systematic review. Ann Surg 248:714–720
Padwal R, Brocks D, Sharma AM (2010) A systematic review of drug absorption following bariatric surgery and its theoretical implications. Obes Rev 11:41–50
Guelinckx I, Devlieger R, Vansant G (2009) Reproductive outcome after bariatric surgery: a critical review. Hum Reprod Update 15:189–201
Eerdekens A, Debeer A, Van Hoey G et al (2010) Maternal bariatric surgery: adverse outcomes in neonates. Eur J Pediatr 169:191–196
Marsk R, Jonas E, Rasmussen F, Naslund E (2010) Nationwide cohort study of post-gastric bypass hypoglycaemia including 5,040 patients undergoing surgery for obesity in 1986–2006 in Sweden. Diabetologia. doi:10.1007/s00125-010-1798-5
Goldfine AB, Mun EC, Devine E et al (2007) Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. J Clin Endocrinol Metab 92:4678–4685
Kruseman M, Leimgruber A, Zumbach F, Golay A (2010) Dietary, weight, and psychological changes among patients with obesity, 8 years after gastric bypass. J Am Diet Assoc 110:527–534
Adams TD, Gress RE, Smith SC et al (2007) Long-term mortality after gastric bypass surgery. N Engl J Med 357:753–761
Martin LF (2004) Obesity surgery. McGraw-Hill, New York
Acknowledgements
J. H. Pinkney receives support from the National Institute for Health Research (NIHR) through the Peninsula Collaboration for Leadership in Allied Health Research and Care. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.
Duality of interest
J. H. Pinkney has received lecture fees from Abbott, Allergan, Astra Zeneca, Eli Lilly, GlaxoSmithKline, Novartis, Novo Nordisk, Merck, Roche, Takeda, sanofi aventis and the American Association of Clinical Endocrinologists. He has also received research funding from Takeda and sanofi aventis. A. B. Johnson has received speakers’ honoraria from Novo Nordisk and Eli Lilly. E. A. M. Gale has no duality of interest to declare.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pinkney, J.H., Johnson, A.B. & Gale, E.A.M. The big fat bariatric bandwagon. Diabetologia 53, 1815–1822 (2010). https://doi.org/10.1007/s00125-010-1845-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00125-010-1845-2